Fesoterodine for the treatment of overactive bladder.
Belavic
Jennifer M
JM
University of Pittsburgh Medical Center-Presbyterian, Pittsburgh, PA, USA.
D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D000075202:Contraindications; D004334:Drug Administration Schedule; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
D001559:Benzhydryl Compounds; D018727:Muscarinic Antagonists; C526675:fesoterodine